[ Inglese] What Tests Are Recommended for Myeloma Patients on Bisphosphonates?

Published on

Topics include: Treatment and Understanding

How can myeloma patients on bisphosphonates be proactive about side effect management? Multiple myeloma expert Dr. Ajay Nooka, from the Winship Cancer Institute, shares what tests are recommended to help prevent potential complications, and explains what procedure patients on bisphosphonates should avoid doing. Watch now to find out more.

This town meeting is sponsored by Amgen, Janssen Pharmaceuticals and Adaptive Biotechnologies. It is produced by Patient Power in partnership with Winship Cancer Institute of Emory University.

View more programs featuring and

Produced in association with Winship Cancer Institute

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Margo:

Coming to the other question of can we proactively to see if we can—if there's an amazing modality that can help us to detect ONJ.  There is nothing that we do proactively at this point in time, but the patients who get ONJ are the ones who typically undergo a dental procedure while they're receiving the bisphosphonates.  We typically ask them to hold off for a certain period of time before they go in for any of the dental procedures.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

What Are the Long-Term Effects of Myeloma Treatment?

Myeloma expert Dr. Jonathan Kaufman discusses potential risks for patients on maintenance therapy and how patients can stay proactive through treatment. Watch now to learn.

Published:

Are New Drug Options Changing Treatment Standards and Strategies for Myeloma?

With the addition of more options for therapy, how is the treatment landscape evolving for multiple myeloma? Is the standard of care changing? Tune in to find out now from noted myeloma expert Dr. Elisabet Manasanch.

Published:

Advertisement
Unisciti alla nostra comunità Registrati per eventi Leggi il nostro ultimo blog
Advertisement

Page last updated on February 18, 2019